Kestra Advisory Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

Kestra Advisory Services’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$396K	Buy	3,619 +60	+2%	+$6.69K	﹤0.01%	2711
2026 Q2	$389K	Sell	3,559 -1,314	-27%	-$136K	﹤0.01%	2541
2026 Q1	$506K	Buy	4,873 +2,724	+127%	+$290K	﹤0.01%	2211
2025 Q4	$222K	Buy	+2,149	New	+$209K	﹤0.01%	2800

Other funds holding PPH

J. Safra Asset Management New York $2.3B AUM 21.55% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Adamsbrown Wealth Consultants Wichita, Kansas $548M AUM 16.52% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Rye Brook Capital Greenwich, Connecticut $154M AUM 17.54% 1-Year Est. Return

WT Wealth Management Scottsdale, Arizona $357M AUM 15.82% 1-Year Est. Return

Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

Fluent Financial Dallas, Texas $292M AUM 8.92% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.92% 1-Year Est. Return

New York Life Investment Management New York $14.5B AUM 27.92% 1-Year Est. Return

Kestra Advisory Services's PPH Position: Q3 2026 in Review

Kestra Advisory Services increased its VanEck Pharmaceutical ETF (PPH) stake by 1.7% in Q3 2026, buying an estimated $6.69K and bringing the position to 3,619 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #2711.

Kestra Advisory Services first reported a position in PPH in Q4 2025 and has held it in 4 quarters since. The position peaked at $506K in Q1 2026. 61 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

Kestra Advisory Services held 3,619 shares of VanEck Pharmaceutical ETF worth $396K as of Q3 2026.
Kestra Advisory Services bought 60 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $6.69K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #2711 holding.
Kestra Advisory Services first reported a position in VanEck Pharmaceutical ETF in Q4 2025 and has held it in 4 quarters since.
Kestra Advisory Services's VanEck Pharmaceutical ETF position peaked at $506K in Q1 2026.
61 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.